| Rick Sullivan |
Rick Sullivan is currently the Chief Financial Officer at Senseonics, Inc., as well as the Chief Financial Officer, Secretary & Treasurer at Senseonics Holdings, Inc. He is also a Principal at Hike Financial LLC. Previously, he worked as the Chief Financial Officer at RoosterBio, Inc. Mr. Sullivan completed his undergraduate degree at Salisbury State University and holds an MBA from the Robert H. Smith School of Business. |
| Abhi Chavan |
Abhi Chavan is currently working as the Vice President-Engineering, Research & Development at Senseonics, Inc. He is also a Senior Member at the Institute of Electrical & Electronics Engineers and the IEEE Engineering in Medicine & Biology Society. Additionally, he holds the position of Vice President-Engineering, Research & Development at Senseonics Holdings, Inc. Previously, he worked as the Vice President-Research & Product Development at Medtronic Monitoring, Inc. Dr. Chavan completed his graduate degree at Syracuse University, his doctorate at the University of Michigan, and his undergraduate degree at the University of Baroda. |
| Mukul Kumar Jain |
Mukul Kumar Jain is currently the Director at Lambent Technologies Pvt Ltd., Director at Sequelone Solutions Pvt Ltd., Director at Mehai Technology Ltd., Chief Operating Officer at Senseonics, Inc., and Chief Operating Officer at Senseonics Holdings, Inc. Previously, he worked as a Senior Program Manager at Medtronic, Inc. from 1999 to 2012. He also held positions as Principal at HCL Technologies Ltd. and Chief Operating Officer at GlobalLogic, Inc. Dr. Jain holds a doctorate degree from the University of South Carolina, an undergraduate degree from the Indian Institute of Technology Kanpur, and an MBA from The Curtis L. Carlson School of Management. |
| Katherine S. Tweden |
Katherine S. Tweden was the founder of EnteroMedics, Inc. founded in 2002, where she held the title of Vice President-Clinical & Regulatory from 2012 to 2015. She currently holds the position of Vice President-Clinical Sciences at Senseonics, Inc. and Senseonics Holdings, Inc. Katherine's former positions include Senior Research Scientist at St. Jude Medical LLC from 1990 to 1997, Vice President at Venturi Group LLC, Vice President-Research at Heartstent Corp. from 1997 to 2002. Katherine received her graduate and doctorate degrees from Iowa State University and her undergraduate degree from Gustavus Adolphus College. |
| Francine R. Kaufman |
Francine R. Kaufman is currently the Chief Executive Officer at Clinical Products LLC and the Director & Chief Medical Officer at Senseonics, Inc. She is also a Director & Chief Medical Officer at Senseonics Holdings, Inc., a Professor at the University of Southern California, a Member of the American Academy of Pediatrics, a Professor at the Keck School of Medicine of USC, and a Partner and Advisor at JDRF T1D Fund. In the past, Dr. Kaufman served as the Chairman of the National Academy of Medicine (United States), Chairman of the National Diabetes Education Program, Vice President-Global Medical Affairs & CMO at Medtronic MiniMed, Inc., President of the American Diabetes Association, and Head-Centre for Endocrinology at Children's Hospital Los Angeles. Dr. Kaufman completed her undergraduate degree at Northwestern University in 1972. She also attended Rosalind Franklin University of Medicine & Science and obtained an undergraduate degree. She earned her doctorate degree from Chicago Medical School in 1976. |
| Stephen P. DeFalco |
Stephen P. DeFalco currently works at Creation Technologies LP, as Chairman & Chief Executive Officer from 2019, Creation Technologies, Inc., as Chairman & Chief Executive Officer from 2019, Senseonics Holdings, Inc., as Chairman from 2015, and Creation Technologies Illinois, Inc., as President. Mr. DeFalco also formerly worked at Crane & Co., Inc., as President, Chief Executive Officer & Director from 2011 to 2018, Nordion (Canada), Inc., as President & Chief Executive Officer from 2005 to 2010, Senseonics, Inc., as Chairman & Chief Executive Officer from 2010 to 2011, PathoGenetix, Inc., as Chairman & Chief Executive Officer, BioProcessors Corp., as Director, United Technologies Corp., as Principal, Revvity, Inc., as Senior Vice President, McKinsey & Co., Inc., as Partner from 1983 to 1992, Goldberg Lindsay & Co. LLC, as Partner from 2018 to 2019, and Perkinelmer Instruments LLC, as President. Mr. DeFalco received his undergraduate degree from Massachusetts Institute of Technology, graduate degree from Syracuse University, and Masters Business Admin degree from MIT Sloan School of Management. |
| Timothy T. Goodnow |
Timothy T. Goodnow is the President, Chief Executive Officer & Director of Senseonics Holdings, Inc. since 2015. Prior to this, he was the President, Chief Executive Officer & Director of Senseonics, Inc. from 2011 to 2015. He was also the Vice President-Technical Operations at Abbott Diabetes Care, Inc. from 2000 to 2011 and the Vice President-Research & Development at TheraSense, Inc. He worked as a Principal at Baxter Healthcare Corp., Verax Biomedical, Inc., and Dade Behring, Inc. Dr. Goodnow received his undergraduate and doctorate degrees from the University of Miami. |
| Douglas A. Roeder |
Douglas A. Roeder is currently the Director at Ivantis, Inc. He is also an Independent Director at Senseonics Holdings, Inc. since 2015 and a Managing Partner at Delphi Ventures, Inc. since 2000. Previously, Mr. Roeder held positions as a Director at Boston Scientific Corp., TriVascular, Inc., Anulex Technologies, Inc., Nuvesse Skin Therapies, Inc., EBR Systems, Inc., Vibrynt, Inc., Tandem Diabetes Care, Inc., Evalve, Inc., Senseonics, Inc., Labcyte, Inc., TranS1, Inc., Soteira, Inc., Trivascular Technologies, Inc., Trivascular2, Inc., Alex. Brown & Sons, Inc., and Putnam Associates LLC. Mr. Roeder completed his undergraduate degree at Dartmouth College in 1993. |
| Sharon D. Larkin |
Sharon D. Larkin is currently the Director at Senseonics, Inc. and an Independent Director at Senseonics Holdings, Inc. Previously, she worked at Abbott Laboratories as the Divisional VP-HR & Medical Devices Group from 2011 to 2015. She also served as the Senior VP-Human Resources & Administration at Assertio Therapeutics, Inc. from 2017 to 2020. Ms. Larkin completed her undergraduate degree at Georgia Institute of Technology. |
| Steven V. Edelman |
Steven V. Edelman is a director, founder, independent director, and professor. He founded Taking Control of Your Diabetes in 1995. He is currently a director at Senseonics, Inc., an independent director at Senseonics Holdings, Inc., and a professor at the University of California San Diego. He is also the Director of the Diabetes Care Clinic at VA Medical Center (District of Columbia). He started working as a professor at Veterans Affairs Healthcare System of San Diego in 2001. Dr. Edelman received his undergraduate and graduate degrees from the University of California, Los Angeles, and his doctorate from the University of California, Davis. |
| Anthony R. Raab |
Anthony R. Raab is currently a Director at Senseonics, Inc. and an Independent Director at Senseonics Holdings, Inc. He is also a Senior Investment Research Analyst at Masters Capital Management LLC. Previously, he worked as an Analyst at TCW Asset Management Co. LLC from 2003 to 2006 and as a Partner & Portfolio Manager at Perimeter Capital Partners LLC. Raab received his undergraduate degree from Duke University in 2003. |
| Douglas S. Prince |
Douglas S. Prince is currently the Director at Creation Technologies LP and Independent Director at Senseonics Holdings, Inc. He previously worked as the Director at Senseonics, Inc., Principal at General Electric Capital Corp. and Aeroquip-Vickers, Inc., Vice President-Finance at Revvity, Inc., Chief Financial Officer & Treasurer at Crane & Co., Inc., Chief Financial Officer at Nordion (Canada), Inc., and Chief Financial Officer at Northern Power Systems Corp. He completed his undergraduate degree at the University of Kentucky. |
| Edward J. Fiorentino |
Edward J. Fiorentino is the founder of Actient Pharmaceuticals LLC, which was founded in 2009. He served as the Chief Executive Officer from 2009 to 2013. He is also the founder of TerSera Therapeutics LLC, which was founded in 2016. He currently holds the position of Executive Chairman & Chief Executive Officer at TerSera Therapeutics LLC. Mr. Fiorentino's current job(s) include being a Director at the Illinois Biotechnology Industry Organization and an Independent Director at Senseonics Holdings, Inc. He started his position as an Independent Director at Senseonics Holdings, Inc. in 2015. Mr. Fiorentino's former job(s) include being the Chairman & Chief Executive Officer at Crealta Pharmaceuticals LLC from 2013 to 2016. He also served as a Director at Senseonics, Inc. from 2012 to 2015. Additionally, he held positions at TAP Pharmaceutical Products, Inc., Abbott Laboratories, Bristol Myers Squibb Co., and Abbott Diabetes Care, Inc.Mr. Fiorentino's education history includes an MBA from Syracuse University and an undergraduate degree from The State University of New York. |
